Free Trial

Bright Health Group (BHG) Competitors

Bright Health Group logo
$6.75 +0.01 (+0.15%)
As of 09/11/2025

BHG vs. ACRS, IMRX, TRDA, HRTX, ELMD, CVRX, ACIU, SLS, GNFT, and UTMD

Should you be buying Bright Health Group stock or one of its competitors? The main competitors of Bright Health Group include Aclaris Therapeutics (ACRS), Immuneering (IMRX), Entrada Therapeutics (TRDA), Heron Therapeutics (HRTX), Electromed (ELMD), CVRx (CVRX), AC Immune (ACIU), SELLAS Life Sciences Group (SLS), GENFIT (GNFT), and Utah Medical Products (UTMD). These companies are all part of the "medical" sector.

Bright Health Group vs. Its Competitors

Bright Health Group (NYSE:BHG) and Aclaris Therapeutics (NASDAQ:ACRS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, dividends, valuation, earnings, profitability, risk, institutional ownership and media sentiment.

Aclaris Therapeutics has lower revenue, but higher earnings than Bright Health Group. Aclaris Therapeutics is trading at a lower price-to-earnings ratio than Bright Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bright Health Group$2.76B0.02-$1.46B-$208.73-0.03
Aclaris Therapeutics$18.72M11.28-$132.07M-$1.37-1.42

Aclaris Therapeutics has a consensus target price of $8.71, suggesting a potential upside of 346.89%. Given Aclaris Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Aclaris Therapeutics is more favorable than Bright Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bright Health Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Aclaris Therapeutics
0 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
3.11

In the previous week, Aclaris Therapeutics had 4 more articles in the media than Bright Health Group. MarketBeat recorded 4 mentions for Aclaris Therapeutics and 0 mentions for Bright Health Group. Aclaris Therapeutics' average media sentiment score of 0.89 beat Bright Health Group's score of 0.00 indicating that Aclaris Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
Bright Health Group Neutral
Aclaris Therapeutics Positive

98.3% of Aclaris Therapeutics shares are owned by institutional investors. 58.4% of Bright Health Group shares are owned by insiders. Comparatively, 5.6% of Aclaris Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Bright Health Group has a net margin of -85.40% compared to Aclaris Therapeutics' net margin of -802.03%. Bright Health Group's return on equity of 0.00% beat Aclaris Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Bright Health Group-85.40% N/A -10.26%
Aclaris Therapeutics -802.03%-34.01%-24.18%

Bright Health Group has a beta of 0.93, meaning that its stock price is 7% less volatile than the S&P 500. Comparatively, Aclaris Therapeutics has a beta of 0.27, meaning that its stock price is 73% less volatile than the S&P 500.

Summary

Aclaris Therapeutics beats Bright Health Group on 10 of the 17 factors compared between the two stocks.

Get Bright Health Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for BHG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BHG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BHG vs. The Competition

MetricBright Health GroupHospital & medical service plans IndustryMedical SectorNYSE Exchange
Market Cap$130.51M$130.51M$5.87B$21.68B
Dividend YieldN/AN/A5.68%3.48%
P/E Ratio-0.03N/A74.5229.69
Price / Sales0.020.02549.7870.28
Price / CashN/AN/A37.5625.00
Price / Book-0.27N/A12.164.58
Net Income-$1.46B-$1.46B$3.28B$1.00B
7 Day Performance1.05%1.05%0.87%0.65%
1 Month PerformanceN/AN/A4.96%3.07%
1 Year Performance23.63%23.63%60.74%14.34%

Bright Health Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BHG
Bright Health Group
N/A$6.75
+0.1%
N/A+33.7%$130.51M$2.76B-0.032,840
ACRS
Aclaris Therapeutics
2.8146 of 5 stars
$1.99
+3.1%
$8.71
+337.9%
+66.7%$209.08M$18.72M-1.45100Positive News
Gap Down
IMRX
Immuneering
3.4332 of 5 stars
$5.99
+4.2%
$13.00
+117.0%
+493.7%$208.83M$320K-3.1760
TRDA
Entrada Therapeutics
2.7059 of 5 stars
$5.38
-1.6%
$25.67
+377.1%
-64.5%$208.06M$210.78M-3.02110News Coverage
HRTX
Heron Therapeutics
4.2268 of 5 stars
$1.32
-2.2%
$4.50
+240.9%
-31.5%$206.94M$144.29M-66.00300Positive News
ELMD
Electromed
3.9061 of 5 stars
$23.95
-3.2%
$36.25
+51.4%
+31.0%$206.48M$64M31.93160Insider Trade
CVRX
CVRx
2.7598 of 5 stars
$7.73
-1.5%
$14.00
+81.1%
+3.4%$205.29M$51.29M-3.68160Positive News
ACIU
AC Immune
2.4606 of 5 stars
$2.21
+8.3%
$12.00
+443.0%
-20.3%$204.84M$31.02M-3.81140Positive News
Analyst Upgrade
High Trading Volume
SLS
SELLAS Life Sciences Group
1.4124 of 5 stars
$1.83
-4.7%
$7.00
+282.5%
+39.1%$202.17M$1M-5.7210News Coverage
Positive News
GNFT
GENFIT
2.0603 of 5 stars
$3.85
-3.9%
$9.00
+134.0%
+4.8%$200.01M$76.77M0.00120
UTMD
Utah Medical Products
3.2007 of 5 stars
$61.48
-1.2%
N/A-5.4%$199.43M$40.90M16.44180Positive News

Related Companies and Tools


This page (NYSE:BHG) was last updated on 9/13/2025 by MarketBeat.com Staff
From Our Partners